Featured News

 

Latest News

"Collateral Lethality" Offers A new Therapeutic Approach
"Collateral Lethality" Offers A new Therapeutic Approach
News   Jan 20, 2017

Cancerous cells often delete genes that suppress tumor formation, often these genes deletions extend into neighboring genes, this is known as "collateral lethality".

READ MORE

Making Strides in Sickle Cell Disease Research
Making Strides in Sickle Cell Disease Research
News   Jan 20, 2017

The world's largest sickle stem cell disease library will contain a diverse range of samples that can be used to study the disease and develop therapeutics.

READ MORE

Investment boost for OCTIMET Oncology
Investment boost for OCTIMET Oncology
News   Jan 19, 2017

OCTIMET Oncology NV secures over EUR 11 million to develop its highly selective MET kinase inhibitors

READ MORE

New Method That Should Enhance the Discovery of New Drugs and the Study of Proteins
New Method That Should Enhance the Discovery of New Drugs and the Study of Proteins
News   Jan 19, 2017

A team of scientists at The Scripps Research Institute have developed a new method that enhances the discovery of new drugs and the study of proteins. The new method enables researchers to quickly find small molecules that bind to hundreds of thousands of proteins in their native cellular environment.

READ MORE

Pall ForteBio Acquires SensiQ's Pioneer SPR Product line
Pall ForteBio Acquires SensiQ's Pioneer SPR Product line
News   Jan 18, 2017

Pall ForteBio will acquire the assets related to SensiQ's Pioneer product line.

READ MORE

Domainex Improves Fragment Based Drug Discovery Services
Domainex Improves Fragment Based Drug Discovery Services
News   Jan 18, 2017

Addition of Monolith NT from NanoTemper Technologies Ltd. enables Domainex to offer a unique protein production, characterisation, and fragment screening service.

READ MORE

X-Chem and Taiho Pharmaceuticals Collaborate
X-Chem and Taiho Pharmaceuticals Collaborate
News   Jan 18, 2017

The collaboration will grant Taiho access to X-Chem’s DEX™ technology which is based on DNA-encoded libraries of small molecules with more than 120 billion molecules.

READ MORE

Lily Buy CoLucid And Acquire Migraine Drug
Lily Buy CoLucid And Acquire Migraine Drug
News   Jan 18, 2017

Eli Lilly announce purchase of CoLucid pharmaceuticals for $960m. They also acquire their late stage migraine treatment, lasmiditan.

READ MORE

New Hope for Treatment of Rare Blood Disorders
New Hope for Treatment of Rare Blood Disorders
News   Jan 17, 2017

NIH scientists have used CRISPR gene editing to repair gene defects in stems cells from patients with a rare immunodeficiency.

READ MORE

New Hope for Personalized Lung Cancer Treatment
New Hope for Personalized Lung Cancer Treatment
News   Jan 16, 2017

Researchers have identified distinct tumor types within small cell lung cancer and a targeted drug combination that worked well against one of these specific tumor types.

READ MORE